Sirtuins and Resveratrol in Medicine
Sirtuins and Resveratrol in Medicine is a research topic within Geriatrics and Gerontology. Science Explorer counts 15k research works in it since 1951. 31.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of sirtuins, particularly SIRT1-7, in regulating metabolism, aging, and cellular homeostasis. It investigates the impact of resveratrol, NAD+, calorie restriction, and oxidative stress on sirtuin activity and their implications for longevity and age-related diseases. The cluster also delves into the interplay between sirtuins, mitochondria, and cellular energy balance.
- Sirtuins
- Resveratrol
- Metabolism
- Aging
- Mitochondria
- NAD+
- Calorie Restriction
- Oxidative Stress
- Longevity
- Cellular Homeostasis
- Research works
- 15k fractional, since 1951
- In the world top 10%
- 4.5k per year above
- Top-10% rate
- 31.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +19% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Sirtuins and Resveratrol in Medicine research?
By volume, China and the United States publish the most (1.4k and 390 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.4k works
- 2 United States 390 works
- 3 India 196 works
- 4 South Korea 120 works
- 5 Iran 119 works
- 6 Italy 108 works
- 7 Japan 100 works
- 8 Türkiye 88 works
- 9 Egypt 75 works
- 10 Brazil 64 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Sirtuins and Resveratrol in Medicine research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Sirtuins and Resveratrol in Medicine research, followed by China Medical University and Soochow University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
- 2 China Medical UniversityChina 13 works
- 3 Soochow UniversityChina 13 works
- 4 Shanghai Jiao Tong UniversityChina 13 works
- 5 Chongqing Medical UniversityChina 11 works
- 6 Wuhan UniversityChina 11 works
- 7 Sun Yat-sen UniversityChina 11 works
- 8 Sichuan UniversityChina 11 works
- 9 Zhejiang Chinese Medical UniversityChina 11 works
- 10 Huazhong University of Science and TechnologyChina 11 works
Who are the leading researchers in Sirtuins and Resveratrol in Medicine?
The most-cited researchers publishing on Sirtuins and Resveratrol in Medicine include Guido Kroemer and Rosa M. Lamuela‐Raventós.
- 1 Guido Kroemer France 4.2k citations
- 2 Rosa M. Lamuela‐Raventós Spain 3.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Sirtuins and Resveratrol in Medicine research done?
The largest centres of Sirtuins and Resveratrol in Medicine research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China). Among places with at least 20 works in it, it is an unusually large share of all research in Guiyang.
Largest cities, 2022–2025
Where it is the local speciality
- GuiyangCN · 22.3 works5.2×
Location quotient: how much more of its research is in Sirtuins and Resveratrol in Medicine than the world average.
Where is the best place to study Sirtuins and Resveratrol in Medicine?
Among universities, judged by research, China Medical University, Chengdu University of Traditional Chinese Medicine and Zhejiang Chinese Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 72.4 | 51.1% | 12.7× | 13 | +65.4% |
| 2 | Chengdu University of Traditional Chinese MedicineChina | 59.9 | 47.0% | 12.9× | 9 | — |
| 3 | Zhejiang Chinese Medical UniversityChina | 58.8 | 33.5% | 13.2× | 11 | +337.2% |
| 4 | Anhui Medical UniversityChina | 52.0 | 37.5% | 10.7× | 10 | +55.3% |
| 5 | Sichuan Agricultural UniversityChina | 51.1 | 34.9% | 10.8× | 10 | — |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 50.4 | 32.4% | 6.4× | 20 | +3.2% |
| 7 | Jilin UniversityChina | 47.0 | 41.4% | 2.9× | 9 | +262.1% |
| 8 | Xuzhou Medical CollegeChina | 45.9 | 33.9% | 12.5× | 8 | +85.9% |
| 9 | Nanjing Agricultural UniversityChina | 45.4 | 28.8% | 7.3× | 9 | +154.6% |
| 10 | Sichuan UniversityChina | 42.5 | 48.1% | 2.0× | 11 | +38.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Sirtuins and Resveratrol in Medicine research growing?
Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Sirtuins and Resveratrol in Medicine.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.